✦ LIBER ✦

Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer

✍ Scribed by Vivek K. Wadhwa; Robin Weston; Nigel J. Parr

Book ID: 109056224
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 345 KB
Volume: 105
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2009.08956.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single infusion of zoledronic acid to pr

Single infusion of zoledronic acid to prevent androgen deprivation therapy-induced bone loss in men with hormone-naive prostate carcinoma

✍ Takefumi Satoh; Masaki Kimura; Kazumasa Matsumoto; Ken-ichi Tabata; Hiroshi Okus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

Preventive effect of risedronate on bone

Preventive effect of risedronate on bone loss in men receiving androgen-deprivation therapy for prostate cancer

✍ Kazuhiro Ishizaka; Tatsuya Machida; Shuichiro Kobayashi; Naoko Kanbe; Satoshi Ki 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB